Novo Nordisk said on Friday it plans to invest more than 42 billion crowns ($6 billion) in the coming years as it seeks to meet booming demand for its Wegovy weight-loss treatment and other drugs. Read More
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.